EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 24 March 2022

News

Joint Industry Statement on the War in Ukraine
23 March 2022

We are united in our mission of providing treatments and vaccines to all those affected by the war, wherever they are.... Read more

Pharmaceutical industry response to the war in Ukraine
05 October 2022

Supporting people affected by the war Read more

Blogs

Multiple Myeloma Awareness Month: A Commitment to Being Ambitious for Patients
24 March 2022 - Dr. Ali Cimen

I’m optimistic we can change the trajectory of multiple myeloma. We won't settle for anything less. Read more

AI and competitiveness angle from a patient view point
23 March 2022 - Jenny Camaradou

People must be at the heart of everything that is done and it is through appropriate investments in education, training... Read more

Events

DIA Europe 2022
29 March 2022 (Hybrid conference (virtual - Brussels))

Advancing Health Priorities Read more

Sustainable Continence Care Symposium 2022
25 April 2022 (Tampere, Finland)

Technologies and Infrastructures of Sustainable Continence Care Read more

11th European Conference on Rare Diseases & Orphan Products
27 June 2022 (Virtual event)

Putting rare diseases policy into action. Read more

35th Annual Congress of the European Association of Nuclear Medicine
15 October 2022 (CCIB, Barcelona International Convention Centre)

The EANM Annual Congress is the most valuable Nuclear Medicine Meeting worldwide. Read more

What we are reading

Western drugmakers walk ethical tightrope over Russian ties
On 18 March 2022 (Financial Times)

Companies must balance needs of sick patients while also demonstrating opposition to war in Ukraine. Read more

Fake it till you make drugs
On 23 March 2022 (Euractiv)

A new study shines the spotlight again on the scourge of counterfeit drugs, which have consequences on people’s health,... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu